FindTrial
Sign In

Effect of chemotherapy on coagulation profile in Breast Cancer

Effect of Chemotherapy on Coagulation Profile in cases of Breast Carcinoma - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/073458
Enrollment
50
Registered
2024-09-05
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

Interventions

Intervention1: Chemotherapy Drugs: CAF regimen (repeat cycle every 21 days )- Cyclophosphamide 600 mg/m2 IV on Day 1 Doxorubicin 60mg/m2 IV on Day 1 5-flourouracil 600/m2 IV on Day 1 CMF regimen (re

Sponsors

DR WAHIDA IYAMIN HUSSAIN
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All cases of breast carcinoma

Exclusion criteria

Exclusion criteria: 1 patients who are unwilling to participate 2 Patients unwilling to participate

Design outcomes

Primary

MeasureTime frame
Changes in values of - Platelet count PT INR APTT D Dimer Bleeding Time Clotting timeTimepoint: 1 Before starting chemotherapy 2 On Day 3 post chemotherapy 3 On day 14 post chemotherapy—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Debabrata Singha

Silchar Medical College and Hospital

Debabrata.singha12@gmail.com9435072017

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026